Traumatic Brain Injury (TBI) Pathway for Liability Insurers

Traumatic brain injury (TBI) claims are among the most complex and costly personal injury cases. Traditional diagnostics rely on subjective reports, low-sensitivity screenings, or imaging with limited utility beyond the acute phase. This leads to:

• Disputed or exaggerated injury claims
• Unclear severity classification
• Uncertain long-term risk and disability costs
• Prolonged case timelines and higher settlement expenses

Without objective, scalable tools, insurers bear unnecessary financial risk.

An evidence-based TBI pathway with definitive diagnostics and managed care oversight.

At the core of our pathway is a mass spectrometry–based diagnostic that provides:

• Objective confirmation of TBI at any stage (acute, post-acute, or chronic)
• Severity assessment through mechanistically grounded biomarkers
• Risk stratification for long-term cognitive impairment

But BioConnetiX delivers more than a test. We provide a comprehensive managed care pathway that integrates biomarker testing into consistent, protocol-driven care, ensuring clarity, accuracy, cost control, and defensible outcomes.

By embedding TBI biomarker testing into a managed pathway, liability carriers gain:

• Objective Evidence → Clear, defensible diagnostic data to support claim evaluation.
• Severity Classification → Early insight into the likely scale of impairment and long-term costs.
• Predictable Costs → Standardized utilization protocols and financial risk assumed by BioConnetiX.
• Reduced Disputes → Elimination of subjective or inconsistent testing reduces contested claims.
• Faster Resolution → Objective evidence and care pathways streamline decision-making and accelerate settlements.
• Lower Long-Term Liability → Early interventions reduce the risk of long-term cognitive deficits, lowering disability exposure.

Test & Confirm → Objective biochemical confirmation of TBI.

Classify & Stratify → Results quantify injury severity and risk of long-term impairment.

Pathway Management → BioConnetiX manages the clinical pathway end-to-end, aligning diagnostics, care plans, and utilization oversight.

Oversight & Reporting → Independent subspecialist pathologists provide utilization review; real-time dashboards track outcomes against baseline KPIs.

Lower Risk. Greater Clarity. Defensible Outcomes.
With BioConnetiX, insurers can rely on objective, validated science and standardized care management to resolve TBI claims with greater accuracy, consistency, and financial predictability. Early, evidence-based interventions reduce the risk of persistent post-concussive symptoms and long-term cognitive deficits, lowering the overall cost of care and long-term disability exposure.